Director granted RSUs and options at STANDARD BIOTOOLS
STANDARD BIOTOOLS INC. director Frank Witney reported new equity awards that increase his stake in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
STANDARD BIOTOOLS INC. director Frank Witney reported new equity awards that increase his stake in the company. On June 18, 2026, he received 99,116 Restricted Stock Units (RSUs) and a stock option for 175,923 shares with an exercise price of $0.8297 per share.
The RSUs vest in full on the earlier of June 18, 2027 or one day before the next annual stockholder meeting, subject to continued service. The option vests in twelve equal monthly installments beginning July 18, 2026 and expires on June 18, 2036. Following these grants, Witney holds 309,978 common shares directly and 4,225 shares indirectly through a revocable trust, in addition to the new option position.
Insider Trade Summary
Grant/Award: 275,039 shares
Grant/Award
3 txns
Insider
Witney Frank
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) | 175,923 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 99,116 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to buy) — 175,923 contracts (Direct);
Common Stock — 309,978 shares (Direct);
Common Stock — 4,225 shares (Indirect, See footnote)
Footnotes (3)
- F1. Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
- F2. Shares held indirectly by First Amended and Restated Revocable Trust Agreement for The Franklin R. Witney and Catherine J. Caulfield-Witney Trust Agreement Dated September 25, 2009 (dated July 31, 2018).
- F3. The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
RSU grant size: 99,116 RSUs
Stock option grant: 175,923 options
Option exercise price: $0.8297 per share
+3 more
6 metrics
RSU grant size
99,116 RSUs
Granted June 18, 2026; vest on earlier of June 18, 2027 or before next annual meeting
Stock option grant
175,923 options
Granted June 18, 2026; right to buy common stock
Option exercise price
$0.8297 per share
Exercise price for 175,923-share stock option
Option expiration
June 18, 2036
Expiration date of newly granted stock option
Direct common shares after grant
309,978 shares
Direct ownership following the reported transactions
Indirect common shares
4,225 shares
Held through a revocable trust following the report
Key Terms
Restricted Stock Units ("RSUs"), Stock Option (Right to buy), revocable trust, annual meeting of stockholders, +1 more
5 terms
Restricted Stock Units ("RSUs") financial
"Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to buy) financial
"Stock Option (Right to buy) with an exercise price of 0.8297 and expiration date June 18, 2036"
revocable trust financial
"Shares held indirectly by First Amended and Restated Revocable Trust Agreement for The Franklin R. Witney and Catherine J. Caulfield-Witney Trust Agreement..."
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
annual meeting of stockholders financial
"vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders"
vesting financial
"subject to the Reporting Person's continued service through the applicable vesting date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Frank Witney receive from STANDARD BIOTOOLS (LAB)?
Frank Witney received 99,116 Restricted Stock Units and a stock option covering 175,923 shares. Both awards were granted at no cash cost and represent compensation tied to continued service and future company performance over specified vesting schedules.
When do Frank Witney’s RSUs in STANDARD BIOTOOLS (LAB) vest?
The 99,116 RSUs vest in full on June 18, 2027, or one day before the company’s next annual stockholder meeting, whichever occurs first. Vesting is conditioned on Witney’s continued service through the applicable vesting date.
What are the terms of Frank Witney’s new stock option at STANDARD BIOTOOLS (LAB)?
The new stock option covers 175,923 shares of common stock at a $0.8297 exercise price. It vests in twelve equal monthly installments starting July 18, 2026, and remains exercisable until its expiration on June 18, 2036, subject to continued service.
How are Frank Witney’s indirect STANDARD BIOTOOLS (LAB) holdings structured?
The 4,225 indirectly held shares are owned by a First Amended and Restated Revocable Trust Agreement for the Franklin R. Witney and Catherine J. Caulfield-Witney Trust, dated September 25, 2009 and amended July 31, 2018, as disclosed.
Is Frank Witney’s Form 4 transaction a market purchase or sale of LAB stock?
The reported transactions are grants of RSUs and stock options, not open-market purchases or sales. They represent compensation awards provided by STANDARD BIOTOOLS, with vesting tied to future service and standard equity incentive plan conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
